Pharmacolog’s chairman of the board leaves his position at his own request

Pharmacolog i Uppsala AB (publ) announces that Björn Varnestig requests to be dismissed from his position as chairman of the board with immediate effect due to personal reasons.

The company has initiated the process to find a new chairman of the board.

This disclosure contains information that Pharmacolog is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 02-05-2023 11:05 CET.

For more information contact:

Erik Hedlund, acting CEO

Email: erik.hedlund@pharmacolog.se
Phone: +46 70-382 08 41

About Pharmacolog

Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.

The following trademarks are owned and protected by Pharmacolog i Uppsala AB: Pharmacolog™-logo, DrugLog™, WasteLog™, PrepLog™ and Pharmacolog Dashboard™.

Further information regarding the company is available at https://pharmacolog.com/.

The company's Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.